Merck & Co. has posted phase 2 data on zilovertamab vedotin in lymphoma, providing more evidence of the narrow safety and efficacy window that is open to the ROR1-directed antibody-drug conjugate ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor. The update provides a closer look at the hand Merck is holding as it ...

The Texas-based, private equity-backed company that bought DVM Manufacturing LLC and its busy West Chester switchgear factory ...

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Attracting quality publishers takes more than just a signup form. Smart visibility, trust-building, and consistent follow-through - this is what works. Here's a 6-step guide based on what's worked for ...

Merck KGaA has reached an agreement with SpringWorks on a $47-per-share takeover deal that values the US biotech at $3.9 billion. The acquisition – which was confirmed to be in the final stages ...

54. CHICAGO — A treatment that combines two different types of cancer-fighting medicines — Gilead Sciences’ Trodelvy with Merck’s Keytruda — reduced the risk of tumor progression by more ...

Benedict Cumberbatch, Riz Ahmed, Dua Lipa and Annie Lennox are among 300 public figures to have signed an open letter calling on UK Prime Minister Keir Starmer to end the country’s “complicity ...